Heron Therapeutics (HRTX)

• Market cap: $200M
• 1 day: -0.91%
• 5 days: -1.8%
• 1 month: -15.5%
• 3 months: -16.15%
• 6 months: -43.23%
• Year to date: -31.88%
• 1 year: -6.84%
• 5 years: -94.22%
• 10 years: -95.93%
• Sector: Healthcare
• Industry: Biotechnology

About: Heron Therapeutics Inc is a commercial-stage biotechnology company. It is focused on improving the lives of patients by developing treatments that address some of the unmet patient needs. The company's product portfolio consists of APONVIE, SUSTOL, ZYNRELEF, and CINVANTI.

Employees: 122